CD40LG and hepatocellular carcinoma: Since several i.t. therapeutic approaches are well-established for the treatment of HCC, i.t.-injection of Ad-CD40L-DC may also be feasible for patients with HCC in combination with s.c. Ad-mAFP-DC.